Cenplacel-L in patients with moderate-to-severe Crohn's disease
Phase of Trial: Phase I/II
Latest Information Update: 01 Aug 2015
Price : $35 *
At a glance
- Drugs Cenplacel L (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 18 Dec 2012 New trial record
- 24 Oct 2012 Results presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology.
- 01 Oct 2012 Primary endpoint 'Clinical-response-rate' has been met.